Profile data is unavailable for this security.
About the company
PT Millennium Pharmacon International Tbk is an Indonesia-based company, which is engaged in the distribution of pharmaceutical products. Its activities consist of wholesalers of pharmaceuticals, traditional medicine, cosmetics, and medical devices. The Company’s segments include Prescription Medicine, Medical Devices, and Non-prescription Medicine. The Company’s products include Tissue Lovers for Man, Lansoprazole Nulab, Antangin Habbatussauda, Cetaxime Cefotaxime Sodium, OB Herbal, Safe Care Roll On Aromatherapy 10 ml, and others. Tissue Lovers For Man is a refreshing wet wipe which cleanses the skin of sensitive areas. Antangin Habbatussauda is a herbal syrup with the contents of Hakbatussauda, Meniran, and Ginger. Cefotaxime is a drug used to treat a wide variety of bacterial infections. The Company distributes pharmaceutical items, dietary supplements, and medical gadgets across Indonesia, through approximately 33 branch offices and one central warehouse.
- Revenue in IDR (TTM)3.99tn
- Net income in IDR16.80bn
- Incorporated1953
- Employees1.18k
- LocationMillennium Pharmacon International Tbk PTGedung Bank Panin Pusat Lantai 9Jl. Jenderal Sudirman Senayan GeloraJAKARTA SELATAN 10270IndonesiaIDN
- Phone+62 2 127085961
- Fax+62 2 127085958
- Websitehttps://www.mpi-indonesia.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLIS Technologies Ltd | 145.38bn | 10.43bn | 232.32bn | 39.00 | 24.66 | 1.80 | 14.91 | 1.60 | 0.0007 | 0.0007 | 0.0102 | 0.01 | 1.02 | -- | 11.80 | 367,282.10 | 7.31 | -3.44 | 8.17 | -3.97 | -- | -- | 7.18 | -3.72 | 6.32 | 30.35 | 0.0396 | -- | 9.70 | 3.51 | 29.72 | -12.16 | 23.66 | -- |
| Simply Solventless Concentrates Ltd | 380.59bn | 51.64bn | 236.19bn | 192.00 | 9.35 | 0.5967 | 3.27 | 0.6206 | 0.0176 | 0.0176 | 0.2643 | 0.2765 | 0.725 | 1.11 | 7.89 | 159,949.40 | 9.84 | -- | 13.15 | -- | 28.99 | -- | 13.57 | -- | 0.7405 | -0.5981 | 0.3241 | -- | 120.93 | -- | -599.34 | -- | -- | -- |
| Cellectar Biosciences Inc | 0.00 | -316.61bn | 237.85bn | 11.00 | -- | 1.43 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
| BIOGENED SA | 544.94bn | 27.15bn | 241.86bn | 223.00 | 8.91 | 1.17 | 5.58 | 0.4438 | 2.33 | 2.33 | 46.87 | 17.84 | 1.33 | 1.74 | 5.43 | -- | 5.63 | 4.16 | 7.43 | 6.02 | 65.25 | 68.27 | 4.24 | 3.96 | 1.40 | 3.83 | 0.3443 | -- | 16.09 | 18.93 | 14.22 | 35.56 | 8.39 | -- |
| Laboratorio Farmaceutico Erfo SpA | 153.50bn | 7.75bn | 242.73bn | 47.00 | 29.74 | 1.45 | 9.05 | 1.58 | 0.0454 | 0.0454 | 0.8964 | 0.9299 | 0.6734 | 3.86 | 7.09 | 187,405.60 | 4.69 | 9.36 | 5.99 | 11.50 | 38.27 | 47.80 | 6.97 | 15.92 | 1.21 | 19.41 | 0.1559 | -- | 1.59 | 6.03 | -33.74 | -22.47 | -- | -- |
| Nutrition Profess PCL | 582.26bn | 35.59bn | 242.76bn | -- | 6.82 | 0.9218 | 4.09 | 0.4169 | 0.5512 | 0.5512 | 9.02 | 4.08 | -- | -- | -- | -- | -- | -- | -- | -- | 85.40 | -- | 6.11 | -- | 3.71 | 14.40 | 0.1617 | -- | -1.84 | -- | -15.21 | -- | -- | -- |
| Millennium Pharmacon Internationl Tbk PT | 3.99tn | 16.80bn | 243.33bn | 1.18k | 14.49 | 0.8102 | 6.05 | 0.0609 | 13.19 | 13.19 | 3,135.74 | 235.76 | 2.17 | 6.55 | 4.68 | 3,382,665,000.00 | 0.9118 | 1.26 | 4.42 | 5.88 | 8.49 | 8.44 | 0.4208 | 0.5389 | 0.7363 | 1.36 | 0.7385 | 11.73 | 16.45 | 7.51 | -48.84 | 16.53 | 5.53 | 14.87 |
| Hoth Therapeutics Inc | 0.00 | -204.30bn | 247.53bn | 2.00 | -- | 1.75 | -- | -- | -1.06 | -1.06 | 0.00 | 0.5442 | 0.00 | -- | -- | 0.00 | -138.61 | -129.47 | -154.67 | -144.30 | -- | -- | -- | -- | -- | -493.48 | 0.00 | -- | -- | -- | -4.37 | -- | -- | -- |
| Phapros Tbk PT | 856.09bn | -209.56bn | 248.64bn | 1.26k | -- | 0.638 | -- | 0.2904 | -249.48 | -249.48 | 1,019.16 | 463.99 | 0.547 | 2.36 | 1.88 | 649,537,700.00 | -13.71 | -2.15 | -21.02 | -4.11 | 41.26 | 48.61 | -25.06 | -3.95 | 1.02 | -2.19 | 0.6425 | -- | -25.80 | -7.60 | -3,721.67 | -- | -13.99 | -- |
| Sotac Pharmaceuticals Ltd | 150.92bn | 16.14bn | 254.44bn | 67.00 | 15.77 | 2.46 | 9.06 | 1.69 | 7.87 | 7.87 | 73.61 | 50.39 | 0.6818 | 2.86 | 2.67 | 12,149,600.00 | 8.46 | 5.81 | 16.28 | 12.47 | 37.26 | 25.59 | 12.40 | 4.69 | 0.9737 | 2.30 | 0.3854 | -- | -6.59 | 27.66 | 124.25 | 146.89 | 11.66 | -- |
